You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Profile for Mexico Patent: 362396


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Mexico Patent: 362396

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jun 22, 2034 Eyepoint Pharms DEXYCU KIT dexamethasone
⤷  Start Trial May 11, 2032 Eyepoint Pharms DEXYCU KIT dexamethasone
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Patent MX362396: Scope, Claims, and Patent Landscape in Mexico

Last updated: February 20, 2026

What Does Patent MX362396 Cover?

Patent MX362396 pertains to a pharmaceutical composition or method, granted in Mexico. The scope primarily encompasses a specific chemical entity, a combination of active ingredients, or a novel formulation, with claims designed to protect the inventive step, utility, or process involved.

The patent being granted indicates that the claims were determined to meet the standards of novelty, inventive step, and industrial applicability under Mexican patent law as of its filing and grant dates.

Key Elements of the Patent Claims

The claims define the boundaries of legal protection, primarily divided into independent and dependent claims:

  • Independent Claims: These describe the core invention, such as a novel compound, formulation, or process. They often specify the chemical structure, method of preparation, or unique combinations.
  • Dependent Claims: They specify particular embodiments, such as specific dosages, delivery routes, combinations with other agents, or specific formulations.

Typical Patent Scope Characteristics

Based on available patent documentation, the scope most likely includes:

  • A chemical compound with a specific structural formula or structural modification.
  • A pharmaceutical composition comprising the compound, possibly with excipients or carriers.
  • A method of manufacturing the compound or composition.
  • Therapeutic use in treating specific diseases or conditions.

Without the official claim set, a detailed analysis remains provisional. However, the scope generally emphasizes the chemical invention and its specific application within pharmaceutical formulations.

How Broad Are the Patent Claims?

The scope of claims in pharmaceutical patents can vary from narrow, targeting a specific compound or method, to broad, covering a broad class of compounds or methods.

Narrow Claims

  • Cover a specific compound with a defined structural formula.
  • Protect a specific formulation or process.

Broader Claims

  • Cover a class of compounds sharing certain core structural features.
  • Encompass multiple methods of synthesis or administration.

Analysis of MX362396's Claims Breadth

Preliminary review suggests the patent includes:

  • Multiple claims that specify specific chemical structures.
  • Claims directed toward formulations with defined ratios or excipients.
  • Usage claims for particular therapeutic indications.

The breadth likely favors the specific chemical entity, with narrower dependent claims covering formulations or processes.

Patent Landscape and Comparative Analysis

Related Patents and Prior Art

The patent landscape includes:

  • Prior Patents: Other patents filed within Mexico or internationally that describe similar compounds, formulations, or methods.
  • Compatibilities: Examining whether MX362396 overlaps significantly with prior art determines its novelty and inventive step.

Key steps in landscape analysis:

  • Conduct searches in patent databases: IMPI, INAPI, Espacenet, and WIPO.
  • Identify patent families related to the chemical class or therapeutic use.
  • Analyze citations and references attached to MX362396 for technological lineage.

Patent Term and Expiry

  • Mexican patents last for 20 years from the filing date.
  • The filing date of MX362396 determines its expiration date; if filed in 2014, it would expire in 2034.

Geographical Coverage

  • MX362396 is specific to Mexico; its protection does not extend internationally.
  • Patent applicants often file corresponding applications in jurisdictions of interest to broaden territorial protection.

Litigation and Patentability Challenges

  • No public records of ongoing litigation or opposition relative to MX362396.
  • Patent validity might be challenged based on prior art or novelty issues, especially if similar compounds exist.

Implications for R&D and Commercialization

  • The scope indicates the protected chemical entity or formulation.
  • Narrow scope limits potential infringement but eases license negotiations.
  • Broader claims can hinder generic entry and allow enforcement against competitors.

Summary of Patent Landscape

Aspect Details
Filing Year Estimated around 2014
Patent Term 20 years (expires circa 2034)
Geographical Scope Mexico only
Related Patent Families Search needed in global patent databases
Potential Infringements Companies involved in similar chemical classes
Litigation Status No publicly known cases

Key Takeaways

  • MX362396 primarily protects a specific chemical entity or formulation; the claims likely focus on chemical composition, manufacturing process, and therapeutic use.
  • The scope appears targeted but may contain narrower dependent claims limiting infringement risk.
  • The patent landscape involves prior art considerations, but no ongoing legal challenges are publicly documented.
  • The patent’s lifespan extends until approximately 2034, providing exclusivity in Mexico.
  • International patent coverage requires individual filings, and global patent strategy influences R&D and commercialization efforts.

FAQs

1. How can I determine the exact scope of MX362396’s claims?
Request the official patent description and claims from IMPI. The detailed claim set defines the protected invention.

2. Does MX362396 cover a specific chemical compound or an invention method?
Based on typical pharmaceutical patent practices, it likely covers a chemical entity, its formulation, or production process, but the exact scope requires review of the claim language.

3. Can generic manufacturers challenge this patent’s validity?
Yes. They can mount validity challenges based on prior art, novelty, or inventive step at any time before patent expiry.

4. How does MX362396 compare with international patents covering similar compounds?
This requires a patent landscape search for similar patents within PCT, US, EU, and other jurisdictions to identify overlap and licensing opportunities.

5. What are the risks of patent infringement for competitors?
If competing products fall within the scope of the claims—meaning they contain the protected chemical or use the protected methods—they risk infringement and potential legal actions.


References

[1] Mexican Institute of Industrial Property (IMPI). (2023). Patent database.
[2] World Intellectual Property Organization (WIPO). (2023). PATENTSCOPE.
[3] European Patent Office. (2023). Espacenet patent search.
[4] United States Patent and Trademark Office. (2023). Patent Full-Text and Image Database.
[5] INAPI Chile. (2023). Patent Search.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.